References
- 1. Liu L, Zhu K, Yu W, Zhang S, Teng G, Guo J. Detection Rate, Anatomic Sites, and Pathologic Types of Colorectal Cancer During Colonoscopy Procedures. Surg Laparosc Endosc Percutan Tech. 2017; 27(5):394-399.10.1097/SLE.000000000000045628906418
- 2. Shen F, Cui J, Cai K, Pan H, Bu H, Yu F. Prognostic accuracy of different lymph node staging systems in rectal adenocarcinoma with or without preoperative radiation therapy. Jpn J Clin Oncol. 2018; 1;48(7):625-632.10.1093/jjco/hyy07029788392
- 3. Bochis OV, Fekete Z, Vlad C, Fetica B, Leucuta DC, Busuioc CI, Irimie A. The importance of a multidisciplinary team in rectal cancer management. Clujul Med. 2017; 90(3):279–285.10.15386/cjmed-689553620728781524
- 4. Fulop ZZ, Gurzu S, Bara T, Dragus E, Bara T Jr, Voidazan S, Banias L, Jung I. Lymph node ratio, an independent prognostic factor for patients with stage II-III rectal carcinoma. Pathol Res Pract. 2019; 215(6):152384.10.1016/j.prp.2019.03.01330910253
- 5. Fazeli MS, Keramati MR. Rectal cancer: a review. Med J Islam Repub Iran. 2015; 29: 171.
- 6. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, Colditz GA. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004; 20;108(3):433-42.10.1002/ijc.11540290321714648711
- 7. Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012; 15;156(10):703-9.10.7326/0003-4819-156-10-201205150-0000622586009
- 8. Stintzing S. Management of colorectal cancer. F1000Prime Rep2014, 6:108.10.12703/P6-108422972825580262
- 9. National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer Version 3.2018, National Comprehensive Cancer Network, 2018.
- 10. Zuo ZG, Zhang XF, Wang H, Liu QZ, Ye XZ, Xu C, Wu XB, Cai JH, Zhou ZH, Li JL, Song HY, Luo ZQ, Li P, Ni SC, Jiang L. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision. Medicine (Baltimore). 2016; 95(9):e2988.10.1097/MD.0000000000002988478290226945418
- 11. Chandrasinghe PC, Ediriweera DS, Hewavisenthi J, Kumarage S, Deen KI. Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer. Indian J Gastroenterol. 2014; 33(3):249-53.10.1007/s12664-013-0406-224048680
- 12. Rivadulla-Serrano MI, Martínez-Ramos D, Armengol-Carrasco M, Escrig-Sos J, Paiva-Coronel GA, Fortea-Sanchís C, Salvador-Sanchís JL. Impact of the total number of harvested lymph nodes after colon cancer resections on survival in patients without involved lymph node. Rev Esp Enferm Dig. 2010; 102(5):296-301.10.4321/S1130-0108201000050000220524756
- 13. Sclafani F, Wilson SH, Cunningham D, Gonzalez De Castro D, Kalaitzaki E, Begum R, Wotherspoon A, Capdevila J, Glimelius B, Roselló S, Thomas J, Tait D, Brown G, Oates J, Chau I. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. Int J Cancer. 2020; 1;146(1):94-102.10.1002/ijc.32507
- 14. Wojas-Krawczyk K, Kalinka-Warzocha E, Reszka K, Nicoś M, Szumiło J, Mańdziuk S, Szczepaniak K, Kupnicka D, Lewandowski R, Milanowski J, Krawczyk P. Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study. Adv Clin Exp Med. 2019; 28(1):67-73.10.17219/acem/76162
- 15. Ágoston EI, Baranyai Z, Dede K, Bodoky G, Kulka J, Bursics A, Harsányi L, Szász AM. Occurrence, intratumoral heterogeneity, prognostic and predictive potential of microsatellite instability following surgical resection of primary colorectal carcinomas and corresponding liver metastases. Orv Hetil. 2015; 6;156(36):1460-71.
- 16. Stanczak A, Stec R, Bodnar L, Olszewski W, Cichowicz M, Kozlowski W, Szczylik C, Pietrucha T, Wieczorek M, Lamparska-Przybysz M. Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma. Pathol Oncol Res. 2011; 17(4):955-63.10.1007/s12253-011-9409-4
- 17. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008; 134(5):1296-310.10.1053/j.gastro.2008.02.098
- 18. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009; 7;373(9666):811-20.10.1016/S0140-6736(09)60484-0